外科学

Medicine & Life Sciences

1. Liver 100%
2. Gastrectomy 82%
3. Hepatocellular Carcinoma 82%
4. Rectal Neoplasms 69%
5. Robotics 62%
6. Stomach Neoplasms 50%
7. Hepatectomy 44%
8. dai-kenchu-to 41%
9. Neoplasms 39%
10. Chemoradiotherapy 38%
11. Propensity Score 37%
12. Recurrence 36%
13. Neoplasm Metastasis 31%
14. Drug Therapy 29%
15. Esophagectomy 29%
16. Minimally Invasive Surgical Procedures 25%
17. Colorectal Neoplasms 23%
18. Lymph Nodes 23%
19. Cholangiocarcinoma 21%
20. Crohn Disease 21%
21. Gastrointestinal Stromal Tumors 20%
22. Lymph Node Excision 19%
23. Japan 18%
24. Laparoscopy 18%
25. Squamous Cell Carcinoma 18%
26. Surgical Anastomosis 18%
27. Morbidity 17%
28. Colonic Neoplasms 17%
29. Liver Diseases 17%
30. Surgeons 16%
31. Pathologic Constriction 16%
32. Gastroenterostomy 15%
33. Survival 15%
34. Therapeutics 14%
35. Chronic Disease 14%
36. Segmental Mastectomy 14%
37. Fibrosis 13%
38. Retrospective Studies 13%
39. Carcinoma 13%
40. Survival Rate 13%
41. Esophageal Neoplasms 12%
42. Breast 12%
43. Imatinib Mesylate 12%
44. Prolapse 12%
45. Liver Neoplasms 11%
46. Colectomy 11%
47. Tomography 11%
48. Liver Transplantation 11%
49. Anastomotic Leak 11%
50. Ileus 11%
51. Observational Studies 10%
52. Placebos 10%
53. Length of Stay 10%
54. Cohort Studies 10%
55. Hepatic Veins 9%
56. Gases 9%
57. Colon 9%
58. Ascites 9%
59. Liver Cirrhosis 9%
60. Dissection 9%
61. Intestinal Pseudo-Obstruction 8%
62. polysaccharide-K 8%
63. Postoperative Complications 8%
64. Colostomy 8%
65. Fluorouracil 8%
66. Operative Time 8%
67. Ileitis 8%
68. Stomach 8%
69. Rectocele 8%
70. Angiodysplasia 8%
71. Ischemic Colitis 8%
72. Bile Ducts 8%
73. Child 8%
74. Focal Nodular Hyperplasia 8%
75. Klatskin Tumor 8%
76. Diverticulitis 8%
77. Plasma Cell Granuloma 7%
78. Body Mass Index 7%
79. Fistula 7%
80. Breast Implants 7%
81. Randomized Controlled Trials 7%
82. Intraoperative Monitoring 7%
83. Safety 7%
84. Small Intestine 7%
85. Intestinal Neoplasms 7%
86. Bacterial Translocation 7%
87. Recurrent Laryngeal Nerve 7%
88. Incidence 7%
89. Portal Vein 7%
90. Ascending Colon 7%
91. Lymphadenitis 7%
92. Erlotinib Hydrochloride 7%
93. Combined Modality Therapy 7%
94. Cardiac Tamponade 7%
95. Cholecystitis 7%
96. Upper Gastrointestinal Tract 6%
97. Curriculum 6%
98. Gastrointestinal Motility 6%
99. Nomograms 6%
100. Virtual Reality 6%